Mepolizumab Effectiveness in Patients With Chronic Rhinosinusitis, Nasal Polyps and Comorbid Severe Eosinophilic Asthma

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

September 3, 2025

Study Completion Date

December 20, 2025

Conditions

Chronic Rhinosinusitis With Nasal PolypsSevere Eosinophilic AsthmaChronic Rhinosinusitis Without Nasal Polyps

Interventions

DRUG

Mepolizumab 100 MG

Monthly administartion of mepolizumab 100mg

Trial Locations (2)

RECRUITING

Pulmonary Dept First ICU, Evagelismos Hospital, Athens

RECRUITING

Pulmonary Dept First ICU Evangelismos Hospital, Athens

All Listed Sponsors

lead

National and Kapodistrian University of Athens

OTHER